EAM
BSX icon

Eventide Asset Management’s Boston Scientific BSX Stock Holding History

Eventide Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Buy
46,071
+3,815
+9% +$207K 0.03% 192
2026
Q1 		$2.65M Buy
42,256
+1,785
+4% +$143K 0.04% 176
2025
Q4 		$3.87M Buy
40,471
+3,055
+8% +$300K 0.06% 170
2025
Q3 		$3.64M Buy
37,416
+2,314
+7% +$240K 0.06% 150
2025
Q2 		$3.76M Buy
35,102
+2,979
+9% +$301K 0.07% 147
2025
Q1 		$3.23M Buy
32,123
+4,886
+18% +$492K 0.06% 153
2024
Q4 		$2.43M Buy
27,237
+18,482
+211% +$1.63M 0.04% 165
2024
Q3 		$734K Buy
+8,755
New +$690K 0.01% 177

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Eventide Asset Management's BSX Position: Q2 2026 in Review

Eventide Asset Management increased its Boston Scientific (BSX) stake by 9% in Q2 2026, buying an estimated $207K and bringing the position to 46,071 shares worth $1.98M. The position accounts for 0.03% of the portfolio, ranked #192.

Eventide Asset Management first reported a position in BSX in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.87M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Eventide Asset Management held 46,071 shares of Boston Scientific worth $1.98M as of Q2 2026.
  • Eventide Asset Management bought 3,815 Boston Scientific shares in Q2 2026, an estimated $207K.
  • Boston Scientific made up 0.03% of Eventide Asset Management's portfolio in Q2 2026, its #192 holding.
  • Eventide Asset Management first reported a position in Boston Scientific in Q3 2024 and has held it in 8 quarters since.
  • Eventide Asset Management's Boston Scientific position peaked at $3.87M in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.